- Showcasing Intelligent RT, Auto Segmentation and an updated MR
Radiation Therapy Suite, designed to optimize the radiation
oncology care pathway and help reduce the critical time between
patient intake and first treatment dose
GE HealthCare (Nasdaq: GEHC) is presenting three new global
innovations – Intelligent Radiation Therapy (iRT), Auto
Segmentation, and an updated Magnetic Resonance (MR) Radiation
Therapy Suite (AIR Open Coil Suite) – that underscore the company’s
commitment to enhancing the radiation oncology care pathway. Each
of these novel solutions, which will be showcased at the European
Society for Therapeutic Radiology and Oncology (ESTRO) 2023
Congress, were designed to help empower clinicians to provide the
highest level of personalized care by enabling access to the
diagnostics, technologies and data needed to make informed and
confident decisions, with the hope of helping patients live their
healthiest lives.
Nearly two-thirds of all cancer patients receive radiation
therapy (RT), a type of treatment that can either be given alone or
in combination with surgery and/or chemotherapy.1 However, it can
take weeks for a patient to go from a cancer diagnosis to treatment
– a delay that may have a significant impact on patient outcomes.
According to research published by the British Medical Journal
(BMJ), the mortality risk increases 6-13% for every month a
diagnosis is delayed.2 GE HealthCare helps address this challenge
by improving and accelerating the radiation oncology care pathway –
a strategic initiative that focuses on broadening the company’s
imaging portfolio, accelerating workflows through enabling seamless
interoperability between radiation therapy systems, and empowering
clinicians with the ability to choose the best technologies for
their patients through an open, vendor-agnostic ecosystem.
The introduction of the following innovations is a testament to
the company’s commitment to creating a best-in-class ecosystem that
enables precision radiation therapy for patients facing cancer
diagnoses around the world:
Intelligent Radiation Therapy (iRT) Radiation therapy
patient workflow management is uniquely complex with various
anatomy care pathways, multiple clinicians managing each patient,
and several software applications and workflow systems that do not
seamlessly share information. GE HealthCare worked closely with
more than 150 clinicians globally, from community hospitals to
leading healthcare institutions, to develop the new iRT platform
which enables greater interoperability, connectivity, and
efficiency throughout the entirety of the radiation oncology care
continuum. Key features include an integrated workflow that
connects various applications into an intuitive single interface,
multi-vendor interoperability that connects existing RT systems
through an automated backend service, seamless data transfer and
task automation, and a catalog of RT applications from both GE
HealthCare and third parties.
The open ecosystem enabled by iRT and other GE HealthCare
technologies is enhanced through the company’s strategic
collaborations with other industry-leading companies, which help
ensure clinicians are supported with precision care solutions at
every step in the care pathway. Current collaborators in the
radiation therapy space include Accuray, Elekta,
RaySearch and Spectronic Medical. Additionally, the
company has established the following new partnership to help drive
clinical outcomes:
- Sun Nuclear: A leading provider of quality management
solutions for diagnostic imaging and radiation therapy centers
worldwide. Its SunCHECK Platform standardizes workflows and
centralizes data management for patient and machine quality
assurance in radiation therapy, enabling increased departmental
efficiency, improved treatment quality, and enhanced patient
safety. The iRT ecosystem is slated for compatibility with SunCHECK
Patient Software.
Auto Segmentation GE HealthCare is also streamlining the
process of delineating organs at risk (OARs) with the introduction
of Auto Segmentation. Delineation of OARs helps ensure a patient’s
tumor receives the maximum dose of radiation therapy, while
minimizing the exposure to surrounding tissue. However, the current
manual process of delineating each organ on each computed
tomography (CT) slice can be time-consuming, with significant
variability. Recently 510(k) cleared by the U.S. FDA and CE Marked,
Auto Segmentation is a deep learning, algorithm-based application
that reads CT images and automatically contours and labels the OARs
to accelerate this process and standardize its outputs. This
algorithm is the latest example of GE HealthCare’s continued
investment in artificial intelligence (AI) to build large
foundational models to reduce the time needed to bring in new
products and unlock untapped capabilities in CT.
An Updated AIR Open Coil Suite The AIR Open Coil Suite is
a comprehensive imaging suite that plays a crucial role in the
planning and guidance of radiation therapy. This advanced
technology helps enable clinicians to more effectively characterize
disease, plan treatment options, target tumors, preserve healthy
tissue, assess response to therapy and improve patient comfort. To
help provide increased patient comfort and procedure efficiency, it
features the use of flexible and lightweight AIR coils and scan
time that is reduced by up to 50%.3 The suite consists of three
separate AIR coils designed for clinically beneficial
signal-to-noise ratio, offers improved image quality that may
reduce the need for repeat scans, and a new tabletop design that
accommodates all necessary patient immobilization devices and
eliminates the need to purchase a separate board.
“These new technologies may help transform the future of
radiation therapy by optimizing and accelerating the oncology care
pathway, as we know that is critical for the outcomes of patients
battling cancer across the globe,” said Ben Newton, PhD, general
manager, Oncology Solutions, at GE HealthCare. “We are streamlining
the radiation therapy workflow by connecting currently disparate
multi-vendor applications system, using artificial intelligence to
automate complex manual steps like organ segmentation and
minimizing the duration of advanced simulation procedures within
magnetic resonance, enabling a simplified process for providers and
a reduced timeline to treatment for patients.”
All three innovations will be exhibited at the GE HealthCare
booth (#1440) at the ESTRO 2023 Congress in Vienna, Austria from
May 12-16. To learn more about iRT, Auto Segmentation, AIR Open
Coil Suite, and other GE HealthCare products, please visit our
booth or gehealthcare.com.
About GE HealthCare Technologies Inc. GE HealthCare is a
leading global medical technology, pharmaceutical diagnostics, and
digital solutions innovator, dedicated to providing integrated
solutions, services, and data analytics to make hospitals more
efficient, clinicians more effective, therapies more precise, and
patients healthier and happier. Serving patients and providers for
more than 100 years, GE HealthCare is advancing personalized,
connected, and compassionate care, while simplifying the patient’s
journey across the care pathway. Together our Imaging, Ultrasound,
Patient Care Solutions, and Pharmaceutical Diagnostics businesses
help improve patient care from diagnosis, to therapy, to
monitoring. We are an $18.3 billion business with 50,000 employees
working to create a world where healthcare has no limits.
Follow us on Facebook, LinkedIn, Twitter, Instagram, and
Insights for the latest news, or visit our website
https://www.gehealthcare.com/ for more information.
______________________________ 1 ASTRO Legislative Priorities.
Available at
https://www.astro.org/uploadedFiles/Main_Site/Meetings_and_Events/2015_Advocacy_Day/Advocacy%20Day%20-%20iPad%20-%20(Linked).pdf.
Accessed April 2023. 2 T. P. Hanna, W. D. King, S. Thibodeau, M.
Jalink, G. A. Paulin, E. Harvey-Jones, D. E. O’Sullivan, C. M.
Booth, R. Sullivan, A. Aggarwal. Mortality due to cancer treatment
delay: systematic review and meta-analysis. The BMJ. DOI:
10.1136/bmj.m4087 3 When used with AIR Recon DL. GE HealthCare data
on file.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230512005026/en/
Karin Dalsin +1 612 219 2855 karin.dalsin@ge.com
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Jul 2023 to Jul 2024